Pharmaceutical Company

Alzheimer’s Drug Fails Study But Flashes Potential

An Alzheimer’s treatment from Eli Lilly and Co. failed to slow memory decline in two separate patient studies, but the drug did show some potential to help in mild cases of the mind-robbing condition that is notoriously difficult to treat.

08/24/2012

(credit: Joe Raedle/Getty Images)

Miracle Diet Pill? A Safe Drug Is Elusive

The battle of the bulge has been a big, fat failure for U.S. drugmakers. But that hasn’t stopped them from trying.

02/24/2012